JAK2 and hepatocellular carcinoma: In this study, based on the fact that the JAK2‐STAT3 signaling pathway can promote the progression of HCC, we observed that the residual tumors after iMWA showed rapid growth and an immunosuppressive state, with high expression levels of JAK‐STAT3‐related proteins.